Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-05-002659
Filing Date
2005-03-16
Accepted
2005-03-16 16:59:32
Documents
9
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 IVAX CORPORATION g93824e10vk.htm 10-K 1135851
2 RESTATED ARTICLES OF INCORPORATION g93824exv3w1.htm EX-3.1 5222
3 WARRANT TO PURCHASE SHARES g93824exv10w14.htm EX-10.14 53291
4 SUBSIDIARIES g93824exv21.htm EX-21 24422
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM g93824exv23w1.htm EX-23.1 2520
6 SECTION 302 CERTIFICATION OF CEO g93824exv31w1.htm EX-31.1 5784
7 SECTION 302 CERTIFICATION OF CFO g93824exv31w2.htm EX-31.2 6001
8 SECTION 906 CERTIFICATION OF CEO g93824exv32w1.htm EX-32.1 4397
9 SECTION 906 CERTIFICATION OF CFO g93824exv32w2.htm EX-32.2 4390
  Complete submission text file 0000950144-05-002659.txt   1244748
Mailing Address 4400 BISCAYNE BOULEVARD MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD MIAMI FL 33137 3055756000
IVAX CORP (Filer) CIK: 0000772197 (see all company filings)

EIN.: 161003559 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-09623 | Film No.: 05686246
SIC: 2834 Pharmaceutical Preparations